MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China — August 9, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June 30, 2010. Highlights for Second Quarter and First Half 2010 — Net revenues were]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China — August 9, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June 30, 2010. Highlights for Second Quarter and First Half 2010 — Net revenues were]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER] [EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his] [CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 --------------------- (principal financial officer and principal accounting officer)]

By | 2016-03-03T20:17:15+00:00 August 9th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x June 30, 2010

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER] [EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his] [CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 --------------------- (principal financial officer and principal accounting officer)]

By | 2016-03-03T20:19:11+00:00 August 9th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SINA [SINA] 6-K: (Original Filing)

[SINA Reports Second Quarter 2010 Financial Results SHANGHAI, China—August 4, 2010— Starting in the fourth quarter of 2009, in addition to the disclosure of GAAP results below, SINA’s historical revenues and certain non-GAAP measures (namely, gross profit, operating expenses, income from operations and advertising gross margin) have been revised to exclude results from China Online Housing Technology Corporation (“COHT”), adjusted] [FORM 6-K SINA Corporation 37F, Jin Mao Tower þ o Form 20-F o o TABLE OF CONTENTS Press Release regarding Results of Operations and Financial Condition for the Second Quarter Ended June 30, 2010, issued by SINA Corporation on August 4, 2010 EX-99.1 SINA CORPORATION Herman Yu Chief Financial Officer 6-K 1 f56561e6vk.htm FORM 6-K]

By | 2016-03-17T19:17:23+00:00 August 9th, 2010|Categories: Chinese Stocks, SEC Original, SINA|Tags: , , , , , |0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: (Original Filing)

[China Automotive Systems Reports 2010 Second Quarter Financial Results - Revenue up 36.2% YoY - - Net Income up 40.6%, diluted EPS $0.28 - WUHAN, China, August 9, 2010 — China Automotive Systems, Inc., (the "Company"), (NASDAQ: CAAS) 2010 Second Quarter Highlights: — Net sales increased 36.2% YoY to a quarterly record of $85.1 million; — Gross margin was 23.3%] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): August 9, 2010 China Automotive Systems, Inc. Delaware 000-33123 33-0885775 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation or organization) Identification No.) Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981]

By | 2016-03-28T18:07:33+00:00 August 9th, 2010|Categories: CAAS, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

SINA [SINA] 6-K: SINA Reports Second Quarter 2010 Financial Results SHANGHAI,

[SINA Reports Second Quarter 2010 Financial Results SHANGHAI, China—August 4, 2010— Starting in the fourth quarter of 2009, in addition to the disclosure of GAAP results below, SINA’s historical revenues and certain non-GAAP measures (namely, gross profit, operating expenses, income from operations and advertising gross margin) have been revised to exclude results from China Online Housing Technology Corporation (“COHT”), adjusted] [FORM 6-K SINA Corporation 37F, Jin Mao Tower þ o Form 20-F o o TABLE OF CONTENTS Press Release regarding Results of Operations and Financial Condition for the Second Quarter Ended June 30, 2010, issued by SINA Corporation on August 4, 2010 EX-99.1 SINA CORPORATION Herman Yu Chief Financial Officer 6-K 1 f56561e6vk.htm FORM 6-K]

By | 2016-03-17T19:18:53+00:00 August 9th, 2010|Categories: Chinese Stocks, SINA, Webplus ver|Tags: , , , , , |0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: China Automotive Systems Reports 2010 Second Quarter Financial

[China Automotive Systems Reports 2010 Second Quarter Financial Results - Revenue up 36.2% YoY - - Net Income up 40.6%, diluted EPS $0.28 - WUHAN, China, August 9, 2010 — China Automotive Systems, Inc., (the "Company"), (NASDAQ: CAAS) 2010 Second Quarter Highlights: — Net sales increased 36.2% YoY to a quarterly record of $85.1 million; — Gross margin was 23.3%] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): August 9, 2010 China Automotive Systems, Inc. Delaware 000-33123 33-0885775 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation or organization) Identification No.) Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981]

By | 2016-03-28T18:09:03+00:00 August 9th, 2010|Categories: CAAS, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar